Why Privacy And Trade Secret Law Are On A Collision Course – JD Supra
Unfortunately, patent coverage does not extend to many of the driving technologies of the so-called Industry 4.0. To protect large data sets, …
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
The numbers behind Via Licensing’s $160.6 million acquisition of MPEG LA – IAM
Who is who: key players in the global RIS patent landscape … Company Number: 03281866 VAT: GB 160 7529 10. Copyright © Law Business Research.
-
In: PATENT NEWS
Climate Mitigation Patent Program Boosts Green Tech Financing – Bloomberg Law News
The US Patent and Trademark Office’s newly expanded program aimed at accelerating patents for climate mitigation technology is critical to …
-
In: PATENT NEWS
Intellectual Property: Patent, Trademark and Copyright Law | U.S. Small Business Administration
Intellectual Property: Patent, Trademark and Copyright Law … As you grow your business, you build value in its name, logos, trademarks, and bylines.
-
In: PATENT NEWS
Samsung, Caltech settle US patent fight over wireless chips – Reuters
Summary; Companies; Law Firms. Caltech patent trial against Samsung was set to begin next month; Caltech previously won $1.1 billion from Apple, …
-
In: PATENT NEWS
Apple Files Patent for Removing Unwanted Graffiti in the Metaverse – Fagen wasanni
Apple Files Patent for Removing Unwanted Graffiti in the Metaverse Fagen wasanni
-
In: PATENT NEWS
Samsung, Caltech settle US patent fight over wireless chips – Reuters
Samsung, Caltech settle US patent fight over wireless chips Reuters
-
In: PATENT NEWS
Federal Circuit Patent Watch: Pending, non-final litigation or IPR decision does not negate …
Read a compilation of our biweekly summaries and corresponding links to recent precedential opinions issued by the United States Court of Appeals …
-
In: PATENT NEWS
Federal Circuit Patent Watch: Pending, non-final litigation or IPR … – WilmerHale
Federal Circuit Patent Watch: Pending, non-final litigation or IPR … WilmerHale
-
In: PATENT NEWS
More drugmakers file continuation patents that sideline generics – STAT
More drugmakers file continuation patents that sideline generics STAT